Document is current
Any future updates will be listed below
-
Authors
Buchanan, Kendall L. https://orcid.org/0000-0002-8003-3421
Liopyris, Konstantinos
Nelson, Kelly C.
Stein, Jennifer A.
Dusza, Stephen W.
Ruiz de Luzuriaga, Arlene
Seiverling, Elizabeth V.
-
Funding
Funding for this research was provided by:
Memorial Sloan-Kettering Cancer Center (P30 CA008748)
- License Information
-
More Information
Article History
Received: 26 July 2024
Revised: 19 August 2024
Accepted: 14 September 2024
First Online: 26 September 2024
Declarations
:
: This study was performed under the umbrella of the International Dermoscopy Society. IRB exemption was previously obtained by the Memorial Sloan Kettering Cancer Center. In 2023, the project was continued solely as a program evaluation for quality improvement purposes and did not require additional IRB exemption.
: Teams registered online through SignUp Genius and verbally consented to participate in the Dermoscopy Bowl.
: (A) Kendall Buchanan; (B) Konstantinos Liopyris; (C) Kelly Nelson; (D) Jennifer Stein; (E) Stephen Dusza; (F) Arlene Ruiz de Luzuriaga; (G) Elizabeth SeiverlingFinancial interest: Author A is a paid consultant for DermaSensor, Modern Ritual, and MetaOptima. Author B is a consultant for FotoFinder, now owned by DermLite, and has received honoraria from DermLite in the past. DermLite supported travel and housing for Authors A and B to the AAD meeting in 2023 and 2024. Authors A and B did not receive any consulting fees, honorarium, funding, or other financial compensation for this publication. Author C has received a grant from the Cancer Research Institute of Texas, but no part of this grant was used to support this publication. Author C has no other financial disclosures. Author D has no conflicts of interest to declare. Author E received partial funding from the MSKCC institutional NIH/NCI Cancer Center Support Grant P30 CA008748. Author F is a paid consultant for Tmunity Therapeutics. Author G is a paid consultant for DermaSensor and MelaTech. Non-financial interest: Author E is an unpaid board member of the Chicago Dermatological Society. Authors A, B, C, D, F, and G do not have any non-financial interest to declare.
: Financial interest: Author A is a paid consultant for DermaSensor, Modern Ritual, and MetaOptima. Author B is a consultant for FotoFinder, now owned by DermLite, and has received honoraria from DermLite in the past. DermLite supported travel and housing for Authors A and B to the AAD meeting in 2023 and 2024. Authors A and B did not receive any consulting fees, honorarium, funding, or other financial compensation for this publication. Author C has received a grant from the Cancer Research Institute of Texas, but no part of this grant was used to support this publication. Author C has no other financial disclosures. Author D has no conflicts of interest to declare. Author E received partial funding from the MSKCC institutional NIH/NCI Cancer Center Support Grant P30 CA008748. Author F is a paid consultant for Tmunity Therapeutics. Author G is a paid consultant for DermaSensor and MelaTech. Non-financial interest: Author E is an unpaid board member of the Chicago Dermatological Society. Authors A, B, C, D, F, and G do not have any non-financial interest to declare.
